Option Care Health (NASDAQ:OPCH) Given Hold (C) Rating at Weiss Ratings

Key Points

• Option Care Health's stock has been given a "hold (c)" rating by Weiss Ratings, indicating a cautious outlook for investors.
• Analysts have varied opinions on the stock, with a consensus price target of $35.11 and eight analysts rating it as a Buy.
• The company reported a quarterly earnings per share of $0.41, surpassing analysts' expectations, with revenues increasing by 15.4% year-over-year.

Option Care Health (NASDAQ:OPCH - Get Free Report)'s stock had its "hold (c)" rating reissued by Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Other equities analysts also recently issued research reports about the stock. TD Cowen initiated coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a "hold" rating and a $30.00 price objective for the company. JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Tuesday, September 23rd. Finally, Cowen initiated coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a "hold" rating for the company. Eight analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $35.11.

Option Care Health Trading Up 0.3%

OPCH opened at $27.19 on Wednesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The stock's 50 day moving average price is $28.18 and its 200-day moving average price is $30.69. Option Care Health has a one year low of $21.39 and a one year high of $35.53. The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 21.75, a P/E/G ratio of 1.64 and a beta of 0.88.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the company earned $0.30 EPS. Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts forecast that Option Care Health will post 1.22 EPS for the current year.

Insider Activity

In other Option Care Health news, Director Timothy P. Sullivan purchased 20,000 shares of the stock in a transaction on Thursday, August 21st. The shares were bought at an average cost of $27.51 per share, with a total value of $550,200.00. Following the completion of the acquisition, the director owned 49,229 shares in the company, valued at $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Norman L. Wright purchased 3,411 shares of the stock in a transaction on Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the acquisition, the director owned 15,501 shares of the company's stock, valued at $454,334.31. The trade was a 28.21% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 59,411 shares of company stock valued at $1,627,576 over the last ninety days. 0.64% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Option Care Health

Several hedge funds have recently modified their holdings of OPCH. GAMMA Investing LLC boosted its stake in shares of Option Care Health by 14,129.6% during the 1st quarter. GAMMA Investing LLC now owns 111,560 shares of the company's stock worth $3,899,000 after acquiring an additional 110,776 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Option Care Health by 82.7% during the 1st quarter. UMB Bank n.a. now owns 2,149 shares of the company's stock worth $75,000 after acquiring an additional 973 shares in the last quarter. Portside Wealth Group LLC purchased a new stake in shares of Option Care Health during the 1st quarter worth about $229,000. Farther Finance Advisors LLC boosted its stake in shares of Option Care Health by 434.8% during the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock worth $67,000 after acquiring an additional 1,561 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Option Care Health during the 1st quarter worth about $743,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.